PHASE II STUDY OF TUMOR-SPECIFIC IDIOTYPE AND SOLUBLE GM-CSF VACCINATION

肿瘤特异性独特型和可溶性 GM-CSF 疫苗接种的 II 期研究

• 批准号: 7374160
• 负责人: PATRICIA J HOLMAN
• 金额: $ 0.68万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7374160
• 关键词: active immunization; lymphoma; neoplasm /cancer; stem cell transplantation

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Evaluate the ability of Id-KLH and GM-CSF to induce cellular and humoral immune responses in patients with low-grade B-cell/mantle cell lymphoma following autologous stem cell transplantation. Evaluate the ability of Id-KLH and GM-CSF to induce or maintain complete clinical or molecular remission in patients with low-grade B-cell/mantle cell lymphoma following autologous stem cell transplantation

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。评价Id-KLH和GM-CSF在自体干细胞移植后低级别B细胞/套细胞淋巴瘤患者中诱导细胞和体液免疫应答的能力。评价Id-KLH和GM-CSF诱导或维持低级别B细胞/套细胞淋巴瘤患者自体干细胞移植后完全临床或分子缓解的能力